Novavax CEO John Jacobs said in a statement that the approval was a "significant milestone" that solidifies a path for people ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

RFK Jr’s FDA limits use of Covid vaccine - Vaccine expert says health secretary wants to ‘make vaccines less available, more ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...

The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump ...

According to approval letter, the license restricts the use of vaccine called Nuvaxovid to individuals aged 65 and older, and ...